Citation Impact
Citing Papers
Platelet gene expression and function in patients with COVID-19
2020 Standout
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
2020 Standout
Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregation
1976 StandoutNobel
Epidemiological characteristics of platelet aggregability.
1985
Scintigraphic Assessment of Regionalized Defects in Myocardial Sympathetic Innervation and Blood Flow Regulation in Diabetic Patients With Autonomic Neuropathy
1998
Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration
1995 StandoutNobel
Some aspects of the neurotransmitter control of anterior pituitary function
1989
Peroxynitrite and Vascular Endothelial Dysfunction in Diabetes Mellitus
2004
Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy
2000
Phospholipid-Cytochrome c Interaction
2002
Estrogen receptor α is a major mediator of 17β-estradiol’s atheroprotective effects on lesion size in Apoe–/– mice
2001 StandoutNobel
A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis
1995 Standout
Diabetic neuropathy and oxidative stress
2006
The Science of Stroke: Mechanisms in Search of Treatments
2010 Standout
Transient receptor potential channels: targeting pain at the source
2008 StandoutNobel
Mitochondria, oxidative stress and cell death
2007 Standout
Vascular Endothelial Growth Factor and Angiogenesis
2004 Standout
Regulation of insulin secretion and reactive oxygen species production by free fatty acids in pancreatic islets
2011
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Nutrition and platelet function in atherogenesis
1987
Androgenic Anabolic Steroid Abuse and the Cardiovascular System
2009
Growth–Defense Tradeoffs in Plants: A Balancing Act to Optimize Fitness
2014 Standout
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
CNS‐specific prostacyclin ligands as neuronal survival‐promoting factors in the brain
1999 StandoutNobel
Mechanisms of plant defense against insect herbivores
2012 Standout
Anabolic/androgenic steroid abuse and thrombosis: Is there a connection?
1991
Androgenic-Anabolic Steroid Abuse and Platelet Aggregation: A Pilot Study in Weight Lifters
1992
Phase equilibria of cholesterol/dipalmitoylphosphatidylcholine mixtures: deuterium nuclear magnetic resonance and differential scanning calorimetry
1990 Standout
Aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis
2009
Expression of genes encoding antioxidant enzymes in human and mouse oocytes during the final stages of maturation
1999
A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis
1995 Standout
Essential fatty acids in growth and development
1991 Standout
Platelet α2-adrenergic receptors in hypercholesterolemia: Relationship between binding studies and epinephrine-induced platelet aggregation
1997
The pathogenesis of atherosclerosis: a perspective for the 1990s
1993 StandoutNature
Age-related changes in serotonin content and its release reaction of rat platelets
1989
Oxidants, antioxidants, and the degenerative diseases of aging.
1993 Standout
Molecular Insights and Therapeutic Targets for Diabetic Endothelial Dysfunction
2009
MICROALBUMINURIA AS A PREDICTOR OF CLINICAL NEPHROPATHY IN INSULIN-DEPENDENT DIABETES MELLITUS
1982 Standout
Eicosanoids in regulation of arterial smooth muscle cell phenotype, proliferative capacity, and cholesterol metabolism.
1989
Diabetic Nephropathy: Diagnosis, Prevention, and Treatment
2005 Standout
Pathogenesis of Diabetic Neuropathy
1998
Granzyme A in Human Platelets Regulates the Synthesis of Proinflammatory Cytokines by Monocytes in Aging
2017
Current trends in the evolutionary ecology of plant defence
2010
Effects of all CIS-5, 8,11,14,17 eicosapentaenoic acid and PGH3 on platelet aggregation
1979 StandoutNobel
Increased prostaglandin production by glomeruli isolated from rats with streptozotocin-induced diabetes mellitus.
1985
HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATION
1977 StandoutNobel
Morphine-like drugs inhibit the stimulation by E prostaglandins of cyclic AMP formation by rat brain homogenate
1974 Nature
Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein.
1989 StandoutNobel
Guidelines for the Primary Prevention of Stroke
2014 Standout
Binding of (3H)prostaglandin E1 to putative receptors linked to adenylate cyclase of cultured cell clones.
1976 StandoutNobel
Characterization of a genetic difference in the platelet aggregation response of two inbred mouse strains, C57BL/6 and C3H/He
1987
A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregation
1976 StandoutNobel
1 Arachidonate Metabolism in Blood Cells and the Vessel Wall
1986
PLEIOTROPIC EFFECTS OF STATINS
2004 Standout
Purinergic receptors
1976
Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy.
1985 Standout
Aging and Wound Healing
2004 Standout
Effects of estradiol on platelet aggregation in mouse mesenteric arterioles and ex vivo
1985
Cholesterol and the cell membrane
1985
Pathophysiology of Type 2 Diabetes Mellitus
2020 Standout
EIGHTH GADDUM MEMORIAL LECTURE UNIVERSITY OF LONDON INSTITUTE OF EDUCATION DECEMBER 1980: BIOLOGICAL IMPORTANCE OF PROSTACYCLIN
1982
The kidney in diabetes
1981
Adverse Health Consequences of Performance-Enhancing Drugs: An Endocrine Society Scientific Statement
2013 Standout
Molecular Design of Prostaglandin Probes in Brain Research: High, Specific Binding to a Novel Prostacyclin Receptor in the Central Nervous System
2000 StandoutNobel
HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDY
1986 Standout
Prolactin: Structure, Function, and Regulation of Secretion
2000 Standout
Structural-functional relationships in diabetic nephropathy.
1984 Standout
15-Deoxy-16-(m-tolyl)-17,18,19,20-tetranorisocarbacyclin: a simple TIC derivative with potent anti-apoptotic activity for neuronal cells
1999 StandoutNobel
Light Regulation of Plant Defense
2014
Opiate Receptor‐Mediated Inhibition of Adenylate Cyclase in Rat Striatal Plasma Membranes
1982 StandoutNobel
An endoperoxide aggregator (LASS), formed in platelets in response to thrombotic stimuli-purification, identification and unique biological significance
1974
International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes.
1994 Standout
Impaired nuclear responsiveness to cytoplasmic signals in lymphocytes from elderly humans with depressed proliferative responses.
1986 StandoutNobel
Extrapineal melatonin: sources, regulation, and potential functions
2014 Standout
Diabetic Autonomic Neuropathy
2003 Standout
Prostaglandins and Thromboxanes
1978 StandoutNobel
Identification and assay of tetranor-prostaglandin E1 in human urine
1976 StandoutNobel
Biological Aspects of Prostaglandins
1974
The influence of n‐6 and n‐3 fatty acids on kidney phospholipid composition and on eicosanoid production in aging rats
1988
Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets
1977 StandoutNobel
Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the anti-thrombotic properties of vascular endothelium
1977 StandoutNobel
The Vascular Endothelium and Human Diseases
2013 Standout
Platelet Physiology and Abnormalities of Platelet Function
1975 Standout
Correlation of prostaglandin E1 receptor binding with evoked uterine contraction: Modification by disulfide reduction
1974
Age Influence on the Immune System
1980
SIGNALING BY EXTRACELLULAR NUCLEOTIDES
1996 StandoutNobel
Works of Malcolm Johnson being referenced
Genetic expression of hexokinase and glucose phosphate isomerase in late-stage mouse preimplantation embryos: transcription activities in glucose/phosphate-containing HTF and glucose/phosphate-free P1 media
1997
Induced Responses to Herbivory and Jasmonate in Three Milkweed Species
2009
The significance of protein disulfide and sulfhydryl groups in prostaglandin action
1974
The interaction of ferrocytochrome c with long-chain fatty acids and their CoA and carnitine esters.
2000
Decreased vascular prostacyclin in experimental diabetes
1978
Effects of in vitro incorporation of cholesterol and cholesterol analogues into rat platelets
1982
Carnitine-dependent β Oxidation of Prostaglandins
1972
Prostaglandin modification of membrane-bound enzyme activity: A possible mechanism of action?
1973
Sex and age differences in human platelet aggregation
1975 Nature
Ultraviolet light modification of the prostaglandin receptor
1973
The interaction of ferrocytochrome c with long-chain fatty acids and their CoA and carnitine esters
2000